Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)
Turkey · Delayed Price · Currency is TRY 99.70
+4.05 (4.23%)
At close: Oct 6, 2026
IST:ONCSM Revenue
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi had revenue of 221.71M TRY in the quarter ending June 30, 2026, with 2.30% growth. This brings the company's revenue in the last twelve months to 734.91M, up 3.23% year-over-year. In the year 2025, Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi had annual revenue of 709.08M with 44.66% growth.
Revenue (ttm)
734.91M
Revenue Growth
+3.23%
P/S Ratio
3.10
Revenue / Employee
2.01M
Employees
366
Market Cap
2.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 709.08M | 218.90M | 44.66% |
| Dec 31, 2024 | 490.18M | 142.94M | 41.16% |
| Dec 31, 2023 | 347.24M | 54.30M | 18.54% |
| Dec 31, 2022 | 292.94M | 164.95M | 128.88% |
| Dec 31, 2021 | 127.99M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.